Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d0fc2b70675ee19bd5fc464f5ae9061 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243 |
filingDate |
2019-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a370e48458d10595df2573e3ecb14e61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d592c1589d086c9fe55679bc2e80deb5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df22b4b105fb8fff000af659a0554fab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90a4f2e3e0bcd5ea5a5e56464faebdb2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ffb3badaabf158e0bfb3cb2984d7d7b |
publicationDate |
2021-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20210030641-A |
titleOfInvention |
Anticancer theranotic compound activated by anti-angiogenesis and hypoxic environment |
abstract |
The present invention relates to an anti-angiogenic and anti-cancer therapeutic agent activated by a hypoxic environment. |
priorityDate |
2019-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |